期刊文献+

非糖尿病腹膜透析患者糖化血红蛋白水平与颈动脉内中膜厚度的相关性 被引量:4

Correlation between glycosylated hemoglobin and carotid intima- media thickness in nondiabetic peritoneal dialysis patients
原文传递
导出
摘要 目的探讨非糖尿病腹膜透析患者糖化血红蛋白(HbAlc)水平与颈动脉内中膜厚度(CIMT)的相关性,明确HbAlc是否为颈动脉硬化的预测因子。方法选择非糖尿病腹膜透析的成年患者42例[平均年龄(48.2±12.3)岁,男性21例],超声检测CIMT,按CIMT厚度分为两组:CIMT正常组(CIMT〈0.9ITIITI)和CIMT增厚组(CIMT≥0.9mm)。使用Spearman秩相关和多重线性回归分析CIMT的影响因素。结果非糖尿病腹膜透析患者CIMT与年龄、餐后2h血糖、LDL-C、TG、TC、HbAlc呈正相关【r=0.355、0.373、0.416、0.345、0.351、0.456,均P〈0.05),而HbAlc对CIMT的影响最大(β=0.459)。结论在非糖尿病腹膜透析患者中,HbAlc水平与CIMT正相关,HbAlc可能是颈动脉硬化的预测因子。 Objective To investigate the correlation between glycosylated hemoglobin (HbAlc) and carotid intimamedia thickness (CIMT) in non- diabetic peritoneal dialysis patients. Methods Forty-two non-diabetic peritoneal dialysis adult patients were enrolled in this study [mean age was (48.2± 12.3) years, 50% was male]. CIMT was determined by carotid ultrasound. Patients were divided into two groups according to CIMT: CIMT normal group (CIMT 〈 0.9 mm) and CIMT thickening group (CIMT≥0.9 mm). HbAlc, 2-hour postprandial blood glucose (2hPBG) and other factors of the patients were analyzed with Spearman rank correlation and multiple linear regression. Results CIMT was correlated with age, 2hPBG, LDL-C, TG, TC, HbAlc in non-diabetic peritoneal dialysis patients (r = 0.355, 0.373, 0.416, 0.345, 0.351, 0.456, all P 〈 0.05). Multiple linear regression showed that HbAlc was the most powerful influence factor of CIMT(β = 0.459). Conclusion HbAlc level is positively correlated with CIMT and may be a predictor of carotid atherosclerosis in non- diabetic peritoneal dialysis patients.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2013年第3期169-172,共4页 Chinese Journal of Nephrology
关键词 糖化血红蛋白 颈动脉狭窄 腹膜透析 非糖尿病 Glycosylated hemoglobin Carotid stenosis Peritoneal dialysis Non-diabetic
  • 相关文献

参考文献12

  • 1甘红兵,陈孟华,田信奎,汪涛.持续非卧床腹膜透析短期内退出的调查分析[J].中国血液净化,2003,2(8):416-418. 被引量:17
  • 2Heimburger 0,Waniewski J,Werynski A, et al. A quantitativedescription of solute and fluid transport during peritonealdialysis. Kidney Int, 1992, 41: 1320-1332.
  • 3Wohlin M, Sundstrom J, Amlov J, et al. Impaired insulinsensitivity is an independent predictor of common carotidintima-media thickness in a population sample of elderly men.Atherosclerosis, 2003,170: 181-185.
  • 4Saleem T, Mohammad KH,Abdel-Fattah MM, et al. Associationof glycosylated haemoglobin level and diabetes mellitusduration with the severity of coronary artery disease. DiabVase Dis Res, 2008,5: 184-189.
  • 5Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinicalcardiovascular events with carotid intima - media thickness: asystematic review and meta - analysis. Circulation, 2007,115:459-467.
  • 6Vasudevan AR, Bums A, Fonseca VA. The effectiveness ofintensive glycemic control for the prevention of vascularcomplications in diabetes mellitus. Treat Endocrinol, 2006,5:273-286.
  • 7田磊,米树华,苏工,陶红,赵全明,周芸.非糖尿病人群糖化血红蛋白水平与冠心病发病的关系[J].中国糖尿病杂志,2007,15(10):598-600. 被引量:24
  • 8Szeto CC, Chow KM, Kwan BC, et al. New - onsethyperglycemiain nondiabetic Chinese patients started onperitoneal dialysis. Am J Kidney Dis, 2007, 49: 524-532.
  • 9Joosten MM, Pai JK, Bertoia ML, et al. Associations betweenconventional cardiovascular risk factors and risk of peripheralartery disease in men. JAMA, 2012, 308: 1660-1667.
  • 10刘金霞,项洁,卜瑞芳,吴文君,沈泓,王霞娟.2型糖尿病患者血清25-羟维生素D浓度与颈动脉内膜中层厚度的关系[J].中华心血管病杂志,2012,40(2):115-119. 被引量:39

二级参考文献50

  • 1林洁明,林大庆,江朝强,徐琳,刘斌,岳晓军,靳雅丽,Thomas,GN.中老年人糖化血红蛋白水平与颈动脉内膜-中层厚度的相关性研究:广州生物库心血管疾病亚队列[J].中华糖尿病杂志,2010,2(3). 被引量:6
  • 2Kuller LH, Velentgas P, Barzilay J,et al. Diabetes mellitus :subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortaliry[J]. Arterioscler Thrimb Vasc Bio, 2000,20: 823-829.
  • 3Expert Committee on the Diagnosis and Classification of Diabetes Mellitus:Report committee On the diagnosis and classification of diabetes meLlitus [ J ]. Diabetes Care, 2003,26 ( Suppl 1 ) : S5-S20.
  • 4Selvin E ,Coresh J,Golden SH,et al. Glycemic control,atherosclerosis,and risk factors for cardiovascular disease in individuals with diabetes:the atherosclerosis risk in communities study [J ]. Diabetes Care, 2005,28 : 1965-1973.
  • 5Akosah KO, McHugh VL, Barnhart SI, et al. Carotid ultrasound for risk clarification in young to middle-aged adults undergoing elec- tive coronary angiography [ J ]. Am J Hypertens, 2006,19 : 1256- 1261.
  • 6Brook RD, Bard RL,Patel S, et al. A negative carotid plaque area test is superior to other noninvasive atheroselerosis studies for reducing the likelihood of having underlying significant coronary artery diseasse[J]. Arterioscl Thromb Vasc Biol,2006,26:656-662.
  • 7Khaw KT,Wareham N,Luhen R,et al. Gtycated haemoglobin,diabetes,and mortality in men in Norfolk cohort of European prospetive investigation of cancer and nutritin (EPICN-orfolk)[J ]. BMJ, 2001,322:15-18.
  • 8Khaw KT,Wareham N,Bingham S,et al. Association of Hemoglobin Ale with cardiovascular disease and mortality in adults:the European prospective investigation into cancer in Norfolk [ J ]. Ann Intern Med ,2004,141:413-420.
  • 9Chiasson JL,Josse RG, Gomis R, et al. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance:the STOP-NIDDM trial [J]. JAMA, 2003,290: 486-494.
  • 10Gerstein HC. Glycosylated hemoglobin :finally ready for prime time as a cardiovascular risk factor[J]. Ann Intern Med,2004,141: 475-476.

共引文献80

同被引文献33

  • 1Chan A, Flores C, Fan SL. Elevated HbAlc in peritoneal dialysis patients without diabetes mellitus [ J ]. Perit Dial Int, 2006, 26(6) : 718-720.
  • 2Ostgren CJ, Sundstrom J, Svennblad B, et al. Associations of HbA1c and educational level with risk of cardiovascular events in 32, 871 drug-treated patients with Type 2 diabetes: a cohort study in primary care [ J ]. Diabet Med, 2013, 30(5) : e170-e177.
  • 3Luk AO, Ma RC, Lau ES, et al. Risk association of HbAlc variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry [ J ]. Diabetes Metab Res Rev, 2013, 29(5) : 384-390.
  • 4Khaw KT, Wareham N. Glycated hemoglobin as a marker of cardiovascular risk [ J ]. Curr Opin Lipidol, 2006, 17(6) : 637-643.
  • 5Ertem AG, Bagbanci H, Kilic H, et al. Relationship between HbAlc levels and coronary artery severity in nondiabetic acute coronary syndrome patients [ J ]. Turk Kardiyol Dern Ars, 2013, 41(5) : 389-395.
  • 6Szeto CC, Chow KM, Kwan BC, et al. New-onset hyperglycemia in nondiabetic chinese patients started on peritoneal dialysis[J]. Am J Kidney Dis, 2007, 49 (4) : 524-532.
  • 7Lee YK, Lee DH, Kim JK, et al. Lysophosphatidylcholine, oxidized low-density lipoprotein and cardiovascular disease in Korean hemodi- alysis patients: analysis at 5 years of follow-up [ J 1. J Korean Med Sci, 2013, 28 (2): 268-273.
  • 8Arnlov J, Ingelsson E, Sundstrom J, et al. Impact of body mass in- dex and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged menJ. Ciculation, 2010, 121 (2): 230-236.
  • 9Joosten MM, Pai JK, Bertoia ML, et al. Associations between con- ventional cardiovascular risk factors and risk of peripherM artery dis- ease in men[J]. JAMA, 2012, 308 (16) : 1 660-667.
  • 10Hu FB, Stampfer MJ, Haffner SM, et al. Elevated risk of cardiovas- cular disease prior to clinical diagnosis of type 2 diabetes[ J]. Diabe- tes Care, 2002, 25 (7) : 1 129-134.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部